MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.00 (0.00%)
Close on Nov 13, 2026Market cap $8.56MP/E –Yield –
Earnings
MetaVia's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.69
-$0.14 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of MetaVia's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026before the open | – | – | -$0.69 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | – | – | -$0.90 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026after the close | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | – | – | -$0.14 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | – | – | -$0.26 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025after the close | – | – | $0.36 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 20, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024before the open | – | – | -$1.85 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | – | – | -$1.32 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | – | – | -$0.09 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023after the close | – | – | -$0.02 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 24, 2022after the close | – | – | – | Filing |
| Q1 FY2022ended Mar 31, 2022 | Apr 1, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Apr 1, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | – | – | -$0.16 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 15, 2021after the close | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 30, 2020after the close | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 9, 2019before the open | – | – | – | Filing |
| Q4 FY2018ended Dec 31, 2018 | Mar 15, 2019before the open | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 8, 2018after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
MetaVia has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When MetaVia puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases MetaVia filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Update
- Update
- Update
- Results
- Results
- Update
- Update
- Update
- Update
- Results
See a number that looks wrong?